nach oben

Erschienen in:

02.07.2019 | PRECLINICAL STUDIES

Xanthan gum-based hydrogel containing nanocapsules for cutaneous diphenyl diselenide delivery in melanoma therapy

verfasst von: Luana Mota Ferreira, Marcel Henrique Marcondes Sari, Juliana Hofstatter Azambuja, Elita Ferreira da Silveira, Verônica Ferrari Cervi, Marila Crivellaro Lay Marchiori, Silvya Stuchi Maria-Engler, Marcia Rosângela Wink, Jéssica Gonçalves Azevedo, Cristina Wayne Nogueira, Elizandra Braganhol, Letícia Cruz

Erschienen in: Investigational New Drugs | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Summary

The aim of this study was to further evaluate the antitumoral effect of (PhSe)₂-loaded polymeric nanocapsules (NC (PhSe)₂) against a resistant melanoma cell line (SK-Mel-103) and develop a xanthan gum-based hydrogel intending the NC (PhSe)₂ cutaneous application. For the in vitro evaluation, cells were incubated with free (PhSe)₂ or NC (PhSe)₂ (0.7–200 μM) and after 48 h the MTT assay, propidium iodide uptake (necrosis marker) and nitrite levels were assessed. The hydrogels were developed by thickening of the NC (PhSe)₂ suspension or (PhSe)₂ solution with xanthan gum and characterized in terms of average diameter, polydispersity index, pH, drug content, spreadability, rheological profiles and in vitro permeation in human skin. The results showed that NC (PhSe)₂ provided a superior antitumoral effect in comparison to free (PhSe)₂ (IC₅₀ value of 47.43 μM and 65.05 μM, respectively) and increased the nitrite content. Both compound forms induced propidium iodide uptake, suggesting a necrosis-related pathway could be involved in the cytotoxic action of (PhSe)₂. All hydrogels showed pH values around 7, drug content close to the theoretical values (5 mg/g) and mean diameter in the nanometric range. Besides, formulations were classified as non-Newtonian flow with pseudoplastic behavior and suitable spreadability factor. Skin permeation studies revealed that the compound content was higher for the nano-based hydrogel in the dermis layer, demonstrating its superior permeation, achieved by the compound encapsulation. It is the first report on an adequate formulation development for cutaneous application of NC (PhSe)₂ that could be used as an adjuvant treatment in melanoma therapy.

Nur mit Berechtigung zugänglich

Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. Ca-Cancer J Clin 68(1):7–30. https://doi.org/10.3322/caac.21442 CrossRefPubMed

World Health Organization (2017) Skin cancers https://www.who.int/uv/faq/skincancer/en/index1.html. Accessed 16 January 2019

Sondak VK, Gibney GT (2014) indications and options for systemic therapy in melanoma. Surg Clin N Am 94(5):1049. https://doi.org/10.1016/j.suc.2014.07.007 CrossRefPubMed

Rigon RB, Oyafuso MH, Fujimura AT, Goncalez ML, do Prado AH, Gremiao MPD, Chorilli M (2015) nanotechnology-based drug delivery systems for melanoma antitumoral therapy: a review. Biomed Res Int. https://doi.org/10.1155/2015/841817

Nogueira CW, Rocha JBT (2011) Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds. Arch Toxicol 85(11):1313–1359. https://doi.org/10.1007/s00204-011-0720-3 CrossRefPubMed

Rosa RM, Roesler R, Braga AL, Saffi J, Henriques JAP (2007) Pharmacology and toxicology of diphenyl diselenide in several biological models. Braz J Med Biol Res 40(10):1287–1304. https://doi.org/10.1590/S0100-879x2006005000171 CrossRefPubMed

Barbosa NBD, Nogueira CW, Guecheva TN, Bellinaso MD, Rocha JBT (2008) Diphenyl diselenide supplementation delays the development of N-nitroso-N-methylurea-induced mammary tumors. Arch Toxicol 82(9):655–663. https://doi.org/10.1007/s00204-007-0271-9 CrossRef

Posser T, de Paula MT, Franco JL, Leal AS, Rocha JBT (2011) Diphenyl diselenide induces apoptotic cell death and modulates ERK1/2 phosphorylation in human neuroblastoma SH-SY5Y cells. Arch Toxicol 85(6):645–651CrossRef

Melo MT, de Oliveira IM, Grivicich I, Guecheva TN, Saffi J, Henriques JAP, Rosa RM (2013) Diphenyl diselenide protects cultured MCF-7 cells against tamoxifen-induced oxidative DNA damage. Biomed Pharmacother 67(4):329–335. https://doi.org/10.1016/j.biopha.2011.09.012 CrossRefPubMed

10.

Nedel F, Campos VF, Alves D, McBride AJA, Dellagostin OA, Collares T, Savegnago L, Seixas FK (2012) Substituted diaryl diselenides: Cytotoxic and apoptotic effect in human colon adenocarcinoma cells. Life Sci 91(9–10):345–352. https://doi.org/10.1016/j.lfs.2012.07.023 CrossRefPubMed

11.

Prigol M, Nogueira CW, Zeni G, Bronze MR, Constantino L (2013) Physicochemical and biochemical profiling of diphenyl diselenide. Appl Biochem Biotechnol 169(3):885–893. https://doi.org/10.1007/s12010-012-0042-9 CrossRefPubMed

12.

Frank LA, Contri RV, Beck RCR, Pohlmann AR, Guterres SS (2015) Improving drug biological effects by encapsulation into polymeric nanocapsules. Wires Nanomed Nanobi 7(5):623–639. https://doi.org/10.1002/wnan.1334 CrossRef

13.

Basha M (2018) Nanotechnology as a promising strategy for anticancer drug delivery. Curr Drug Deliv 15(4):497–509. https://doi.org/10.2174/1567201814666170516114411 CrossRefPubMed

14.

Friberg S, Nystrom AM (2015) Nanotechnology in the war against cancer: new arms against an old enemy - a clinical view. Future Oncol 11(13):1961–1975. https://doi.org/10.2217/Fon.15.91 CrossRefPubMed

15.

Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S (1989) Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 55(1):R1–R4. https://doi.org/10.1016/0378-5173(89)90281-0 CrossRef

16.

Brigger I, Dubernet C, Couvreur P (2002) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54(5):631–651. https://doi.org/10.1016/S0169-409x(02)00044-3 CrossRefPubMed

17.

Giordani CFA, de Souza D, Dornelles L, Nogueira CW, Alves MP, Prigol M, Rodrigues OED (2014) Diphenyl diselenide-loaded nanocapsules: preparation and biological distribution. Appl Biochem Biotechnol 172(2):755–766. https://doi.org/10.1007/s12010-013-0554-y CrossRefPubMed

18.

Stefanello ST, Dobrachinski F, de Carvalho NR, Amaral GP, Barcelos RP, Oliveira VA, Oliveira CS, Giordani CFA, Pereira ME, Rodrigues OED, Soares FAA (2015) Free radical scavenging in vitro and biological activity of diphenyl diselenide-loaded nanocapsules: DPDS-NCS antioxidant and toxicological effects. Int J Nanomedicine 10. https://doi.org/10.2147/Ijn.S87190

19.

Ferreira LM, Cervi VF, Sari MHM, Barbieri AV, Ramos AP, Copetti PM, de Brum GF, Nascimento R, Nadal JM, Farago PV, Sagrillo MR, Nogueira CW, Cruz L (2018) Diphenyl diselenide loaded poly(epsilon-caprolactone) nanocapsules with selective antimelanoma activity: Development and cytotoxic evaluation. Mat Sci Eng C-Mater 91:1–9. https://doi.org/10.1016/j.msec.2018.05.014 CrossRef

20.

Redpath M, Marques CMG, Dibden C, Waddon A, Lalla R, MacNeil S (2009) Ibuprofen and hydrogel-released ibuprofen in the reduction of inflammation-induced migration in melanoma cells. Brit J Dermatol 161(1):25–33. https://doi.org/10.1111/j.1365-2133.2009.09220.x CrossRef

21.

Li J, Wang YJ, Liang RJ, An XJ, Wang K, Shen GX, Tu YT, Zhu JT, Tao J (2015) Recent advances in targeted nanoparticles drug delivery to melanoma. Nanomed-Nanotechnol 11(3):769–794. https://doi.org/10.1016/j.nano.2014.11.006 CrossRef

22.

Sisti A, Sisti G, Oranges CM (2015) Topical treatment of melanoma skin metastases with Imiquimod: a review. Dermatol Online J 21(2):1–9

23.

Guterres SS, Alves MP, Pohlmann AR (2007) Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications. Drug Target Insights 2:147–157CrossRef

24.

Alves MP, Scarrone AL, Santos M, Pohlmann AR, Guterres SS (2007) Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int J Pharm 341(1–2):215–220. https://doi.org/10.1016/j.ijpharm.2007.03.031 CrossRefPubMed

25.

Marchiori MCL, Rascovetzki RH, Ourique AF, Rigo LA, Silva CB, Beck RCR (2013) Improved tretinoin photostability in a topical nanomedicine replacing original liquid suspension with spray-dried powder with no loss of effectiveness. Drug Dev Ind Pharm 39(4):579–586. https://doi.org/10.3109/03639045.2012.691510 CrossRefPubMed

26.

Melero A, Ourique AF, Guterres SS, Pohlrnann AR, Lehr CM, Beck RCR, Schaefer U (2014) Nanoencapsulation in lipid-core nanocapsules controls mometasone furoate skin permeability rate and its penetration to the deeper skin layers. Skin Pharmacol Physiol 27(4):217–228. https://doi.org/10.1159/000354921 CrossRefPubMed

27.

Rigo LA, da Silva CR, de Oliveira SM, Cabreira TN, da Silva CD, Ferreira J, Beck RCR (2015) Nanoencapsulation of rice bran oil increases its protective effects against UVB radiation-induced skin injury in mice. Eur J Pharm Biopharm 93:11–17. https://doi.org/10.1016/j.ejpb.2015.03.020 CrossRefPubMed

28.

Flores FC, de Lima JA, da Silya CR, Benvegnu D, Ferreira J, Burger ME, Beck RCR, Rolim CMB, Rocha MIUM, da Veiga ML, da Silya CD (2015) Hydrogels containing nanocapsules and nanoemulsions of tea tree oil provide antiedematogenic effect and improved skin wound healing. J Nanosci Nanotechnol 15(1):800–809. https://doi.org/10.1166/jnn.2015.9176 CrossRefPubMed

29.

Beber TC, de Andrade DF, Chaves PD, Pohlmann AR, Guterres SS, Beck RCR (2016) Cationic polymeric nanocapsules as a strategy to target dexamethasone to viable epidermis: skin penetration and permeation studies. J Nanosci Nanotechnol 16(2):1331–1338. https://doi.org/10.1166/jnn.2016.11670 CrossRefPubMed

30.

de Andrade DF, Fontana MC, Pohlmann AR, Guterres SS, Beck RCR (2015) Nanoencapsulation of clobetasol propionate decreases its penetration to skin layers without changing its relative skin distribution. J Nanosci Nanotechnol 15(1):875–879. https://doi.org/10.1166/jnn.2015.9183 CrossRefPubMed

31.

de Lima JA, Paines TC, Motta MH, Weber WB, dos Santos SS, Cruz L, da Silva CD (2017) Novel Pemulen/Pullulan blended hydrogel containing clotrimazole-loaded cationic nanocapsules: Evaluation of mucoadhesion and vaginal permeation. Mat Sci Eng C-Mater 79:886–893. https://doi.org/10.1016/j.msec.2017.05.030 CrossRef

32.

Pegoraro NS, Barbieri AV, Camponogara C, Mattiazzi J, Brum ES, Marchiori MCL, Oliveira SM, Cruz L (2017) Nanoencapsulation of coenzyme Q10 and vitamin E acetate protects against UVB radiation-induced skin injury in mice. Colloid Surface B 150:32–40. https://doi.org/10.1016/j.colsurfb.2016.11.013 CrossRef

33.

Marchiori MCL, Rigon C, Camponogara C, Oliveira SM, Cruz L (2017) Hydrogel containing silibinin-loaded pomegranate oil based nanocapsules exhibits anti-inflammatory effects on skin damage UVB radiation-induced in mice. J Photochem Photobiol B 170:25–32. https://doi.org/10.1016/j.jphotobiol.2017.03.015 CrossRefPubMed

34.

Kumar A, Rao KM, Han SS (2018) Application of xanthan gum as polysaccharide in tissue engineering: A review. Carbohydr Polym 180:128–144. https://doi.org/10.1016/j.carbpol.2017.10.009 CrossRefPubMed

35.

Paulmier C (1986) Selenoorganic functional groups. Selenium reagents and intermediates in organic synthesis. Angew Chem 100:25–51

36.

Stuehr DJ, Nathan CF (1989) Nitric-oxide - a macrophage product responsible for cytostasis and respiratory inhibition in tumor target-cells. J Exp Med 169(5):1543–1555. https://doi.org/10.1084/jem.169.5.1543 CrossRefPubMed

37.

Rigo LA, Weber J, Silva CB, Beck RCR (2012) Evaluation of the spreadability of pharmaceutical or cosmetic semisolid formulations using scanned images. Lat Am J Pharm 31(10):1387–1391

38.

Drewes CC, Fiel LA, Bexiga CG, Asbahr ACC, Uchiyama MK, Cogliati B, Araki K, Guterres SS, Pohlmann AR, Farsky SP (2016) Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models. Int J Nanomedicine 11:1261–1279. https://doi.org/10.2147/Ijn.S101543 CrossRefPubMedPubMedCentral

39.

Fukumura D, Kashiwagi S, Jain RK (2006) The role of nitric oxide in tumour progression. Nat Rev Cancer 6(7):521–534. https://doi.org/10.1038/nrc1910 CrossRefPubMed

40.

Yarlagadda K, Hassani J, Foote IP, Markowitz J (2017) The role of nitric oxide in melanoma. Bba-Rev Cancer 1868(2):500–509. https://doi.org/10.1016/j.bbcan.2017.09.005 CrossRef

41.

Cevc G, Vierl U (2010) Nanotechnology and the transdermal route A state of the art review and critical appraisal. J Control Release 141(3):277–299. https://doi.org/10.1016/j.jconrel.2009.10.016 CrossRefPubMed

42.

Fontana MC, JFP R, Coradini K, DBR L, RCR B (2011) Improved efficacy in the treatment of contact dermatitis in rats by a dermatological nanomedicine containing clobetasol propionate. Eur J Pharm Biopharm 79(2):241–249. https://doi.org/10.1016/j.ejpb.2011.05.002 CrossRefPubMed

43.

Prajapati VD, Jani GK, Moradiya NG, Randeria NP (2013) Pharmaceutical applications of various natural gums, mucilages and their modified forms. Carbohydr Polym 92(2):1685–1699. https://doi.org/10.1016/j.carbpol.2012.11.021 CrossRefPubMed

44.

Junyaprasert VB, Teeranachaideekul V, Souto EB, Boonme P, Müller RH (2009) Q10-loaded NLC versus nanoemulsions: Stability, rheology and in vitro skin permeation. Int J Pharm 377(1–2):207–214. https://doi.org/10.1016/j.ijpharm.2009.05.020 CrossRefPubMed

45.

Rosseti IB, Rocha JBT, Costa MS (2015) Diphenyl diselenide (PhSe)(2) inhibits biofilm formation by Candida albicans, increasing both ROS production and membrane permeability. J Trace Elem Med Biol 29:289–295. https://doi.org/10.1016/j.jtemb.2014.08.001 CrossRefPubMed

46.

Netto G, Jose J (2018) Development, characterization, and evaluation of sunscreen cream containing solid lipid nanoparticles of silymarin. J Cosmet Dermatol-Us 17(6):1073–1083. https://doi.org/10.1111/jocd.12470 CrossRef

47.

Garg A, Aggarwal D, Garg S, Singla AK (2002) Spreading of semisolid formulations. An Update. Pharm Technol 1:84–105

48.

Contri RV, Katzer T, Ourique AF, da Silva ALM, Beck RCR, Pohlmann AR, Guterres SS (2014) Combined effect of polymeric nanocapsules and Chitosan hydrogel on the increase of capsaicinoids adhesion to the skin surface. J Biomed Nanotechnol 10(5):820–830. https://doi.org/10.1166/jbn.2014.1752 CrossRefPubMed

49.

Singh S, Zafar A, Khan S, Naseem I (2017) Towards therapeutic advances in melanoma management: an overview. Life Sci 174:50–58. https://doi.org/10.1016/j.lfs.2017.02.011 CrossRefPubMed

Titel: Xanthan gum-based hydrogel containing nanocapsules for cutaneous diphenyl diselenide delivery in melanoma therapy
verfasst von: Luana Mota Ferreira
Marcel Henrique Marcondes Sari
Juliana Hofstatter Azambuja
Elita Ferreira da Silveira
Verônica Ferrari Cervi
Marila Crivellaro Lay Marchiori
Silvya Stuchi Maria-Engler
Marcia Rosângela Wink
Jéssica Gonçalves Azevedo
Cristina Wayne Nogueira
Elizandra Braganhol
Letícia Cruz
Publikationsdatum: 02.07.2019
Verlag: Springer US
Erschienen in: Investigational New Drugs / Ausgabe 3/2020
Print ISSN: 0167-6997
Elektronische ISSN: 1573-0646
DOI: https://doi.org/10.1007/s10637-019-00823-2

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Xanthan gum-based hydrogel containing nanocapsules for cutaneous diphenyl diselenide delivery in melanoma therapy

Summary

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Cotargeting the JAK/STAT signaling pathway and histone deacetylase by ruxolitinib and vorinostat elicits synergistic effects against myeloproliferative neoplasms

Stimulation of neuroendocrine differentiation in prostate cancer cells by GHRH and its blockade by GHRH antagonists

T cell cytotoxicity toward hematologic malignancy via B7-H3 targeting

Targeting ROS overgeneration by N-benzyl-2-nitro-1-imidazole-acetamide as a potential therapeutic reposition approach for cancer therapy

A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors

Evaluation of absorption, distribution, metabolism, and excretion of [14C]-rucaparib, a poly(ADP-ribose) polymerase inhibitor, in patients with advanced solid tumors

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie